On 2 December 2025, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. published its monthly return for the period ended 30 November 2025, reporting an authorized share capital of RMB 2,670,429,325. This total consists of 551,940,500 H shares and 2,118,488,825 A shares, each with a par value of RMB 1.

The number of issued H shares remains 540,971,500 (excluding 10,969,000 treasury shares), and the number of issued A shares remains 2,098,582,573 (excluding 19,906,252 treasury shares). No changes were recorded in share capital or treasury shares during November. Under the 2025 A Share Option Scheme, 4,535,100 A Share Options were granted on 4 November 2025, and 10,589,500 H Share Restricted Share Units were granted under the 2025 H Share RSU Scheme. Neither program led to any new issuance of shares or transfers from treasury shares in November.